Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-07

Clinical Trial Update: Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of orismilast in atopic dermatitis has completed, with results posted on 2025-03-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orismilast (orismilast)

Snippet

Sponsor: UNION therapeutics | Conditions: Atopic Dermatitis, Skin Diseases | Phase 2 | Status: COMPLETED | Results posted: 2025-03-07